BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 30551361)

  • 1. MiR-217 promotes cell proliferation and osteogenic differentiation of BMSCs by targeting DKK1 in steroid-associated osteonecrosis.
    Dai Z; Jin Y; Zheng J; Liu K; Zhao J; Zhang S; Wu F; Sun Z
    Biomed Pharmacother; 2019 Jan; 109():1112-1119. PubMed ID: 30551361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-155-5p regulates mesenchymal stem cell osteogenesis and proliferation by targeting GSK3B in steroid-associated osteonecrosis.
    Wu F; Huang W; Yang Y; Liu F; Chen J; Wang G; Sun Z
    Cell Biol Int; 2021 Jan; 45(1):83-91. PubMed ID: 32991030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-144-3p Inhibits BMSC Proliferation and Osteogenic Differentiation
    Sun Z; Wu F; Yang Y; Liu F; Mo F; Chen J; Wang G; Zhang B
    Curr Pharm Des; 2019; 25(45):4806-4812. PubMed ID: 31566128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. microRNA-148a-3p in extracellular vesicles derived from bone marrow mesenchymal stem cells suppresses SMURF1 to prevent osteonecrosis of femoral head.
    Huang S; Li Y; Wu P; Xiao Y; Duan N; Quan J; Du W
    J Cell Mol Med; 2020 Oct; 24(19):11512-11523. PubMed ID: 32871042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silencing MicroRNA-137-3p, which Targets RUNX2 and CXCL12 Prevents Steroid-induced Osteonecrosis of the Femoral Head by Facilitating Osteogenesis and Angiogenesis.
    Kong L; Zuo R; Wang M; Wang W; Xu J; Chai Y; Guan J; Kang Q
    Int J Biol Sci; 2020; 16(4):655-670. PubMed ID: 32025213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decrease of MiR-31 induced by TNF-α inhibitor activates SATB2/RUNX2 pathway and promotes osteogenic differentiation in ethanol-induced osteonecrosis.
    Yu L; Xu Y; Qu H; Yu Y; Li W; Zhao Y; Qiu G
    J Cell Physiol; 2019 Apr; 234(4):4314-4326. PubMed ID: 30132874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-15b ameliorates SONFH by targeting Smad7 and inhibiting osteogenic differentiation of BMSCs.
    Fang SH; Chen L; Chen HH; Li YF; Luo HB; Hu DQ; Chen P
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9761-9771. PubMed ID: 31799643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-181d promotes steroid-induced osteonecrosis of the femoral head by targeting SMAD3 to inhibit osteogenic differentiation of hBMSCs.
    Xie Y; Hu JZ; Shi ZY
    Eur Rev Med Pharmacol Sci; 2018 Jul; 22(13):4053-4062. PubMed ID: 30024590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA HULC promotes proliferation and osteogenic differentiation of bone mesenchymal stem cells via down-regulation of miR-195.
    Jiang XR; Guo N; Li XQ; Yang HY; Wang K; Zhang CL; Li GS; Li GD
    Eur Rev Med Pharmacol Sci; 2018 May; 22(10):2954-2965. PubMed ID: 29863237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-203 is essential for the shift from osteogenic differentiation to adipogenic differentiation of mesenchymal stem cells in postmenopausal osteoporosis.
    Qiao L; Liu D; Li CG; Wang YJ
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5804-5814. PubMed ID: 30280759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-203 is involved in osteoporosis by regulating DKK1 and inhibiting osteogenic differentiation of MSCs.
    Xia ZL; Wang Y; Sun QD; Du XF
    Eur Rev Med Pharmacol Sci; 2018 Aug; 22(16):5098-5105. PubMed ID: 30178828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Berberine promotes bone marrow-derived mesenchymal stem cells osteogenic differentiation via canonical Wnt/β-catenin signaling pathway.
    Tao K; Xiao D; Weng J; Xiong A; Kang B; Zeng H
    Toxicol Lett; 2016 Jan; 240(1):68-80. PubMed ID: 26478571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polydatin promotes the osteogenic differentiation of human bone mesenchymal stem cells by activating the BMP2-Wnt/β-catenin signaling pathway.
    Chen XJ; Shen YS; He MC; Yang F; Yang P; Pang FX; He W; Cao YM; Wei QS
    Biomed Pharmacother; 2019 Apr; 112():108746. PubMed ID: 30970530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FHL2 mediates dexamethasone-induced mesenchymal cell differentiation into osteoblasts by activating Wnt/beta-catenin signaling-dependent Runx2 expression.
    Hamidouche Z; Haÿ E; Vaudin P; Charbord P; Schüle R; Marie PJ; Fromigué O
    FASEB J; 2008 Nov; 22(11):3813-22. PubMed ID: 18653765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-139-5p Represses BMSC Osteogenesis via Targeting Wnt/β-Catenin Signaling Pathway.
    Long H; Sun B; Cheng L; Zhao S; Zhu Y; Zhao R; Zhu J
    DNA Cell Biol; 2017 Aug; 36(8):715-724. PubMed ID: 28622009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA HOTAIR inhibits miR-17-5p to regulate osteogenic differentiation and proliferation in non-traumatic osteonecrosis of femoral head.
    Wei B; Wei W; Zhao B; Guo X; Liu S
    PLoS One; 2017; 12(2):e0169097. PubMed ID: 28207735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-19b-3p promotes cell proliferation and osteogenic differentiation of BMSCs by interacting with lncRNA H19.
    Xiaoling G; Shuaibin L; Kailu L
    BMC Med Genet; 2020 Jan; 21(1):11. PubMed ID: 31918667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-291a-3p regulates the BMSCs differentiation via targeting DKK1 in dexamethasone-induced osteoporosis.
    Li ZH; Hu H; Zhang XY; Liu GD; Ran B; Zhang PG; Liao MM; Wu YC
    Kaohsiung J Med Sci; 2020 Jan; 36(1):35-42. PubMed ID: 31729834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA Expression Profiling of Bone Marrow Mesenchymal Stem Cells in Steroid-Induced Osteonecrosis of the Femoral Head Associated with Osteogenesis.
    Wang A; Ren M; Song Y; Wang X; Wang Q; Yang Q; Liu H; Du Z; Zhang G; Wang J
    Med Sci Monit; 2018 Mar; 24():1813-1825. PubMed ID: 29590087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Icariin regulates miR-23a-3p-mediated osteogenic differentiation of BMSCs via BMP-2/Smad5/Runx2 and WNT/β-catenin pathways in osteonecrosis of the femoral head.
    Zhang XY; Li HN; Chen F; Chen YP; Chai Y; Liao JZ; Gan B; Chen DP; Li S; Liu YQ
    Saudi Pharm J; 2021 Dec; 29(12):1405-1415. PubMed ID: 35002378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.